Lipella Pharmaceuticals Inc. (LIPO): Cash & Equivalents
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$2.18M
As of 2024-12-31
$1.86M
As of 2025-09-30
+15.6%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $2.18M | -33.7% | 2025-03-28, Balance as of period end |
| 2023-12-31 | $3.29M | -35.7% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $5.12M | +262.3% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $1.41M | n/a | 2023-03-31, Balance as of period end |